Medtronic announces first surgery with Hugoâ"¢ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic [Accessibility Statement] Skip NavigationNewly FDA-cleared system helps expand patient access to minimally invasive surgeryCleveland Clinic joins nationally recognized academic medical centers including Atrium Health Wake Forest Baptist High Point Medical Center as first hospitals in the U.S. to install Hugo RAS systemGALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic today announce ...

Group 1 - U.S. stock futures are trading lower on Tuesday morning, indicating a potential decline in market sentiment [1] - Certain stocks are expected to attract investor attention today, although specific names are not mentioned [1] - The article suggests checking premarket coverage for more detailed insights into market movements [1]

Austin, United States, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Uterine Fibroid Market Size & Growth Analysis: As Per SNS Insider, The Uterine Fibroid Market size was valued at USD 5.26 Billion in 2025 and is projected to reach USD 9.43 Billion by 2033 and grow at a CAGR of 7.63% over the forecast period 2026-2033. The uterine fibroid market is expanding at a high growth rate due to the increased incidence of uterine fibroids among women of childbearing age in the world. Uterine fibroids, also known as leiomyomas, ...

Retail behemoth Walmart reports pre-market next Thursday, headlining a packed earnings week. The middle of next week is dense, with over 40 companies reporting on both Tuesday and Wednesday. Next Tuesday features a wave of reports from the healthcare and energy sectors, including Medtronic plc. before the bell and tech firm Palo Alto Networks Inc. after close. The current week ends with energy leader Enbridge Inc reporting Friday morning. Disclaimer: This article is for informational purposes only and does ...

I have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoughts with the Seeking Alpha community.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the n ...

Medtronic plc (NYSE:MDT) is included among the 13 Cheapest Dividend Aristocrats to Invest in. Needham Upgrades Medtronic (MDT) to Buy, Sets $121 PT on Product Launch Momentum On February 9, Needham & Company upgraded Medtronic plc (NYSE:MDT) to Buy from Hold. It set a $121 price target on the stock. The firm said the company is still in the early phase of several major product rollouts aimed at multi-billion dollar markets. According to the analyst, these launches should help accelerate revenue growth. N ...

will report financial results on Tuesday, February 17,...]### Medtronic advances its innovation strategy with intent to acquire CathWorks[Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will exercise its option to acquire CathWorks, a privately...][More Releases From This Source]## Explore[Health Care & Hospitals][Medical Equipment][Medical Pharmaceuticals][Computer & Electronics] [News Releases in Similar Topics]---- -- Medtronic receives FDA clearance for Stealth AXi ...

Medtronic plc (NYSE:MDT) will release earnings for its third quarter before the opening bell on Tuesday, Feb. 17.Analysts expect the company to report quarterly earnings of $1.34 per share. That’s down from $1.39 per share in the year-ago period. The consensus estimate for Medtronic's quarterly revenue is $8.9 billion (it reported $8.29 billion last year), according to Benzinga Pro. Needham analyst Mike Matson upgraded Medtronic from Hold to Buy on Monday and set a $121 price target.Medtronic investors may ...

Medtronic plc (NYSE:MDT) will release earnings for its third quarter before the opening bell on Tuesday, Feb. 17.Analysts expect the company to report quarterly earnings of $1.34 per share. That’s down from $1.39 per share in the year-ago period. The consensus estimate for Medtronic's quarterly revenue is $8.9 billion (it reported $8.29 billion last year), according to Benzinga Pro. Needham analyst Mike Matson upgraded Medtronic from Hold to Buy on Monday and set a $121 price target.Medtronic investors may ...

作为全省高端医疗器械产业发展的重要地标，江苏医疗器械科技产业园Medpark深耕医学影像、生物医 用材料、体外诊断、医用机器人等"黄金赛道"，催生出覆盖研发、生产、销售、检测、服务全链条的生 态系统，迎来科技创新与成果转化的春色满"园"。奋进"十五五"，这座产业园正以"升级版"服务加速企 业成长进程，全力打造千亿级医疗器械产业基地。 产业园里创新黑马奔腾 尚美医疗集团总部项目签约落户，打造集研发、生产、销售于一体的总部基地和集团公司；科塞尔与美 敦力签署战略合作，推动冠状动脉棘突球囊扩张导管的临床应用；园内9款产品入围江苏省创新药械产 品目录第三类、第二类创新医疗器械清单……接连不断的好消息，不仅宣告着园内企业的创新突破，更 展现出产业园厚积薄发的产业韧性。 生命健康产业被称为"永不衰落的朝阳产业"，直接关乎人民健康与生命质量，也是衡量一个国家科技进 步与产业实力的重要标志。《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》明确提 出，"支持创新药和医疗器械发展"。 2月2日上午10点，苏州朗目医疗科技有限公司实验室里，工程师们正测试着一款微创青光眼支架产 品。"这款支架大小仅有几十微米，就跟人类头 ...